New AI Agent Automation eliminates manual reporting, automates complex interoperability tasks, and enables system integration when APIs or technical expertise are not available. Healthcare ...

Vertex has doubled down on cell-based therapies for type 1 diabetes (T1D), buying ViaCyte in a $320 million deal that it says will accelerate development of its own candidate VX-880. The deal has been ...